Multicentric Double-blind Placebo-controlled Randomized Parallel-group Clinical Trial of Safety and Efficiency of New Dosage Schedule for Dietressa Drug in Treatment of Obese Patients
Phase of Trial: Phase III
Latest Information Update: 10 Feb 2017
At a glance
- Drugs Anti-CB1 cannabinoid receptor antibody (Primary)
- Indications Obesity
- Focus Registrational; Therapeutic Use
- 01 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Apr 2013 Planned end date changed from 1 Sep 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.
- 24 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.